Apnomed, Inc.

ApnoMed is a healthcare company providing FDA-cleared medical devices and comprehensive treatment solutions for sleep apnea and airway disorders. The company operates a multidisciplinary platform connecting patients with certified providers including dentists, orthodontists, oral surgeons, and myofunctional therapists. ApnoMed specializes in advanced oral appliance therapy designed to manage obstructive sleep apnea and temporomandibular joint (TMJ) disorders while avoiding side effects associated with conventional treatments such as permanent tooth movement and bite changes. The platform spans the full treatment spectrum from pediatric prevention and early intervention to minimally invasive therapies and surgical procedures. ApnoMed's proprietary ApnoDent® hybrid mandibular advancement device has demonstrated a 95% success rate in peer-reviewed clinical studies published in the Journal of Dental Sleep Medicine. The company operates a network of over 400 certified providers and offers comprehensive training programs, certification curricula, and ongoing clinical support. Treatment approaches include non-restrictive orthodontics, myofunctional-friendly oral appliances, and teledontic/telegnathic interventions with emphasis on long-term compliance and airway-centered care.